Clinical Trial: Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional




Official Title: Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers

Brief Summary: ThIS study is to determine whether canakinumab is able to induce and maintain a clinically meaningful reduction of disease activity in participants with Hereditary Periodic Fevers (HPF) compared to placebo.